Comparative pharmacokinetics of perfluorohexanesulfonate (PFHxS) in rats, mice, and monkeys

Reprod Toxicol. 2012 Jul;33(4):441-451. doi: 10.1016/j.reprotox.2011.07.004. Epub 2011 Aug 11.

Abstract

Perfluorohexanesulfonate (PFHxS) has been found in biological samples from wildlife and humans. The human geometric mean serum PFHxS elimination half-life has been estimated to be 2665days. A series of studies was undertaken to establish pharmacokinetic parameters for PFHxS in rats, mice, and monkeys after single administration with pharmacokinetic parameters determined by WinNonlin(®) software. Rats and mice appeared to be more effective at eliminating PFHxS than monkeys. With the exception of female rats, which had serum PFHxS elimination half-life of approximately 2 days, the serum elimination half-lives in the rodent species and monkeys approximated 1month and 4months, respectively, when followed over extended time periods (10-24weeks). Collectively, these studies provide valuable insight for human health risk assessment regarding the potential for accumulation of PFHxS in humans.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Animals
  • Dose-Response Relationship, Drug
  • Environmental Pollutants / blood
  • Environmental Pollutants / pharmacokinetics*
  • Environmental Pollutants / urine
  • Feces / chemistry
  • Female
  • Fluorocarbons
  • Half-Life
  • Injections, Intravenous
  • Liver / metabolism
  • Macaca fascicularis
  • Male
  • Metabolic Clearance Rate
  • Mice
  • Mice, Inbred Strains
  • Rats
  • Rats, Sprague-Dawley
  • Sex Factors
  • Species Specificity
  • Sulfonic Acids / blood
  • Sulfonic Acids / pharmacokinetics*
  • Sulfonic Acids / urine
  • Tissue Distribution

Substances

  • Environmental Pollutants
  • Fluorocarbons
  • Sulfonic Acids
  • perfluorohexanesulfonic acid